Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Staying steady: a new program aims to keep older adults exercising and prevent falls

NCT ID NCT06447948

Disease control Sponsor: Northumbria University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This study tests a program called Keep Exercising and Stay Steady (KESS) designed to help older adults continue exercising after completing fall prevention classes. Many older adults stop exercising once these classes end, losing strength and balance gains and raising their fall risk. The program includes motivational group sessions, educational talks, and text reminders. Researchers are testing it with 30 older adults in England to see if it is acceptable and helps maintain physical activity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a behavioral program called Keep Exercising and Stay Steady (KESS) that uses motivational interviews, group sessions, and text reminders to encourage continued exercise
What this could lead to
If successful, this program could help older adults maintain strength and balance after fall prevention classes, reducing their risk of falls and broken bones.
What could go wrong
This is a small feasibility study with only 30 participants, so results may not apply broadly. The program's success depends on participants' motivation and adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility criteria: * Community dwelling older adults * Enrolled on a Healthworks FaME programme in the Northeast region of England. * Able to provide informed written consent. Exclusion criteria: * Unable to independently walk 5 metres with or without a walking aid. * Advised by a medic not to undertake exercise. * Has a medical, cognitive, or physical condition that prevents safe engagement with digital technology or unsupervised exercise.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fall patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fall patients

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • HealthWorks: The Health Resource Centre, Benwell

    RECRUITING

    Newcastle upon Tyne, Tyne and Wear, NE4 8BE, United Kingdom

  • Healthworks, East End Pool, Byker

    RECRUITING

    Newcastle upon Tyne, Tyne and Wear, NE6 1AL, United Kingdom

  • Healthworks, The Lemington Centre, Wallbottle

    RECRUITING

    Newcastle upon Tyne, Tyne and Wear, NE15 8RZ, United Kingdom

  • Healthworks, Trinity Church, Gosforth

    RECRUITING

    Newcastle upon Tyne, Tyne and Wear, NE3 4AG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.